Dick JRT - Search Results

1

Myostatin inhibition prevents skeletal muscle pathophysiology in Huntington's disease mice.

Bondulich MK, Jolinon N, Osborne GF, Smith EJ, Rattray I, Neueder A, Sathasivam K, Ahmed M, Ali N, Benjamin AC, Chang X, Dick JRT, Ellis M, Franklin SA, Goodwin D, Inuabasi L, Lazell H, Lehar A, Richard-Londt A, Rosinski J, Smith DL, Wood T, Tabrizi SJ, Brandner S, Greensmith L, Howland D, Munoz-Sanjuan I, Lee SJ, Bates GP. Bondulich MK, et al. Among authors: dick jrt. Sci Rep. 2017 Oct 27;7(1):14275. doi: 10.1038/s41598-017-14290-3. Sci Rep. 2017. PMID: 29079832 Free PMC article.

2

HDAC4-myogenin axis as an important marker of HD-related skeletal muscle atrophy.

Mielcarek M, Toczek M, Smeets CJ, Franklin SA, Bondulich MK, Jolinon N, Muller T, Ahmed M, Dick JR, Piotrowska I, Greensmith L, Smolenski RT, Bates GP. Mielcarek M, et al. PLoS Genet. 2015 Mar 6;11(3):e1005021. doi: 10.1371/journal.pgen.1005021. eCollection 2015 Mar. PLoS Genet. 2015. PMID: 25748626 Free PMC article.

3

Deterioration of muscle force and contractile characteristics are early pathological events in spinal and bulbar muscular atrophy mice.

Gray AL, Annan L, Dick JRT, La Spada AR, Hanna MG, Greensmith L, Malik B. Gray AL, et al. Among authors: dick jrt. Dis Model Mech. 2020 May 26;13(5):dmm042424. doi: 10.1242/dmm.042424. Dis Model Mech. 2020. PMID: 32152060 Free PMC article.

4

The effect of peripheral nerve injury on disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.

Sharp PS, Dick JR, Greensmith L. Sharp PS, et al. Neuroscience. 2005;130(4):897-910. doi: 10.1016/j.neuroscience.2004.09.069. Neuroscience. 2005. PMID: 15652988

5

Mechano-growth factor, an IGF-I splice variant, rescues motoneurons and improves muscle function in SOD1(G93A) mice.

Riddoch-Contreras J, Yang SY, Dick JR, Goldspink G, Orrell RW, Greensmith L. Riddoch-Contreras J, et al. Exp Neurol. 2009 Feb;215(2):281-9. doi: 10.1016/j.expneurol.2008.10.014. Epub 2008 Nov 7. Exp Neurol. 2009. PMID: 19038252

6

Plasma neurofilament heavy chain levels correlate to markers of late stage disease progression and treatment response in SOD1(G93A) mice that model ALS.

Lu CH, Petzold A, Kalmar B, Dick J, Malaspina A, Greensmith L. Lu CH, et al. PLoS One. 2012;7(7):e40998. doi: 10.1371/journal.pone.0040998. Epub 2012 Jul 16. PLoS One. 2012. PMID: 22815892 Free PMC article.

7

Manipulating transmitter release at the neuromuscular junction of neonatal rats alters the expression of ChAT and GAP-43 in motoneurons.

Sharp PS, Dekkers J, Dick JR, Greensmith L. Sharp PS, et al. Brain Res Dev Brain Res. 2003 Dec 19;146(1-2):29-38. doi: 10.1016/j.devbrainres.2003.09.005. Brain Res Dev Brain Res. 2003. PMID: 14643009

8

Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice.

Bilsland LG, Dick JR, Pryce G, Petrosino S, Di Marzo V, Baker D, Greensmith L. Bilsland LG, et al. FASEB J. 2006 May;20(7):1003-5. doi: 10.1096/fj.05-4743fje. Epub 2006 Mar 29. FASEB J. 2006. PMID: 16571781

9

[No title available]

[No authors listed] [No authors listed] PMID: 34005080

10

Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice.

Kieran D, Kalmar B, Dick JR, Riddoch-Contreras J, Burnstock G, Greensmith L. Kieran D, et al. Nat Med. 2004 Apr;10(4):402-5. doi: 10.1038/nm1021. Epub 2004 Mar 21. Nat Med. 2004. PMID: 15034571

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

95 results

Search Page